-
Product Insights
Arterial Thrombosis - Drugs In Development, 2024
Empower your strategies with our Arterial Thrombosis – Drugs In Development, 2024 report and make more profitable business decisions. Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale skin, and coldness. Depending on where the clot forms, arterial thrombosis can cause several serious conditions, including stroke, heart attack, and peripheral arterial disease (PAD). Predisposing factors include smoking, obesity, diabetes, hypertension, and high cholesterol level. Treatment includes thrombolytic...
-
Product Insights
Congenital Heart Disease - Drugs In Development, 2024
Empower your strategies with our Congenital Heart Disease – Drugs In Development, 2024 report and make more profitable business decisions. Congenital heart disease is an impairment of the heart’s structure that is present at birth. It may change the normal flow of blood through the heart. It is the most common type of birth defect, occurring in about 1% of live births in the US. There are different types of congenital heart defects; the most common involve the inside walls of...
-
Product Insights
Endomyocardial (Eosinophilic) Disease - Drugs In Development, 2024
Empower your strategies with our Endomyocardial (Eosinophilic) Disease – Drugs In Development, 2024 report and make more profitable business decisions. Eosinophilic endomyocardial disease is characterized by persisting blood eosinophilia and acute endocardial lesions that progress to endomyocardial fibrosis. In most cases the cause is unknown but it has been described in association with malignant tumors. The heart damage appears to be a direct result of tissue injury from toxic eosinophil granule proteins within the heart. The Endomyocardial (Eosinophilic) Disease drugs in...
-
Product Insights
Cardiac Arrest - Drugs In Development, 2024
Empower your strategies with our Cardiac Arrest – Drugs In Development, 2024 report and make more profitable business decisions. Cardiac arrest occurs when the heart suddenly and unexpectedly stops pumping. If this happens, blood stops flowing to the brain and other vital organs. Cardiac arrest is a medical emergency and can be caused by certain types of arrhythmias that prevent the heart from pumping blood. The Cardiac Arrest drugs in development market research report provide comprehensive information on the therapeutics under...
-
Product Insights
Cerebral Infarction (Brain Infarction) - Drugs In Development, 2024
Empower your strategies with our Cerebral Infarction (Brain Infarction) – Drugs In Development, 2024 report and make more profitable business decisions. Cerebral infarction results in an area of necrotic tissue in the brain (a cerebral infarct). It is caused by disrupted blood supply (ischemia) and restricted oxygen supply (hypoxia), most commonly due to thromboembolism, and manifests clinically as ischemic stroke. Major risk factors for cerebral infarction are generally the same as for atherosclerosis. These include high blood pressure, diabetes mellitus, tobacco...
-
Product Insights
Ischemic Cardiomyopathy - Drugs In Development, 2024
Empower your strategies with our Ischemic Cardiomyopathy – Drugs In Development, 2024 report and make more profitable business decisions. Ischemic cardiomyopathy is a type of cardiomyopathy caused by a narrowing of the coronary arteries that supply blood to the heart. Patients with ischemic cardiomyopathy often have a history of acute myocardial infarction (MI), but it may occur in patients with coronary artery disease but no past history of acute MI. This cardiomyopathy is one of the leading causes of sudden cardiac...
-
Product Insights
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) - Drugs In Development, 2024
Empower your strategies with our Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Giant cell arteritis (GCA) is a form of vasculitis, a group of disorders that cause inflammation of blood vessels that affects the arteries of the head (especially the temporal arteries, located on each side of the head). It is also called as temporal arteritis (TA) or cranial arteritis or Horton's syndrome. The Giant Cell Arteritis (Temporal Arteritis/Cranial...
-
Product Insights
Hypotension - Drugs In Development, 2024
Empower your strategies with our Hypotension – Drugs In Development, 2024 report and make more profitable business decisions. Low blood pressure, or hypotension, occurs when blood pressure during and after each heartbeat is much lower than usual. This means the heart, brain, and other parts of the body do not get enough blood. Symptoms include blurred vision, dizziness, confusion, sleeplessness, and weakness. Treatment is required for patients with signs and symptoms. The Hypotension drugs in development market research report provide comprehensive...
-
Product Insights
Left Ventricular Dysfunction - Drugs In Development, 2024
Empower your strategies with our Left Ventricular Dysfunction – Drugs In Development, 2024 report and make more profitable business decisions. Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat, and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism, and coronary artery disease. The Left Ventricular Dysfunction drugs in development market research report provide comprehensive information on the therapeutics under development for Left Ventricular Dysfunction,...
-
Product Insights
Portal Hypertension - Drugs In Development, 2024
Empower your strategies with our Portal Hypertension – Drugs In Development, 2024 report and make more profitable business decisions. Portal hypertension is increased pressure within the portal venous system. It is determined by the increased portal pressure gradient (the difference in pressures between the portal venous pressure and the pressure within the inferior vena cava or the hepatic vein. This pressure gradient is normally less than or equal to 5 mmHg. A pressure gradient of 6 mmHg or more between the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.